Two progressively degenerative diseases, amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease) and frontotemporal dementia (FTD, recently in the news with the diagnoses of actor Bruce Willis and talk ...
Mar 18, 2024
0
131
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this ...
Mar 12, 2024
0
101
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
This week, Western Australia announced a state government-funded immunization program against respiratory syncytial virus (RSV). It's the first Australian state or territory to do so.
Mar 7, 2024
0
0
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study presenting ...
Mar 4, 2024
0
0
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has successfully developed a neutralizing monoclonal antibody, 6H2, which targets a harmful protein known to exacerbate damage caused ...
Feb 27, 2024
0
0
A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the ...
Feb 21, 2024
0
27
In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody that specifically targets a certain type of breast cancer cell. Their findings, published in the International ...
Feb 19, 2024
0
0
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients ...
Feb 16, 2024
0
65
Findings from a new study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering and published in Cell Reports Medicine offer new insights into how antibodies function ...
Feb 12, 2024
0
66
